[Ascending urinary tract infections and vulvovesical reflux--a myth?]

Animal pharmacokinetics of inogatran, a low-molecular-weight thrombin inhibitor with potential use as an antithrombotic drug.

Biopharmaceutics & drug disposition·1998

In vitro effects of inogatran, a selective low molecular weight thrombin inhibitor.

Thrombosis research·1997

Inogatran, a novel direct low molecular weight thrombin inhibitor, given with, but not after, tissue-plasminogen activator, improves thrombolysis.

The Journal of pharmacology and experimental therapeutics·1996

Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1996

Thrombin inhibitors based on ketone derivatives of arginine and lysine.

Journal of enzyme inhibition·1995

Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.

Circulation·1991

[The Swedish Neonatal Quality Register (SNQ) - a complete register for a complex chain of events].

Lakartidningen·2026

[Postoperative atrial fibrillation after open heart surgery].

Lakartidningen·2026

[Interaction between psychotic patients and AI-driven chatbots].

Lakartidningen·2026

[Superficial venous thrombosis of the lower extremities].

Lakartidningen·2026

[Switch from STEMI to OMI].

Lakartidningen·2026

[Maxillomandibular advancement].

Lakartidningen·2026

Late follicular phase progesterone levels and in vitro fertilization and intracytoplasmic sperm injection outcomes.

Frontiers in endocrinology·2026

Influencing factors of fertilization failure during in vitro fertilization.

Frontiers in endocrinology·2026

Astaxanthin and Male Reproductive Health: Mechanisms, Experimental Evidence, and Clinical Perspectives.

Reproductive sciences (Thousand Oaks, Calif.)·2026

Potential and Challenges of Menstrual Blood-derived Mesenchymal Stem Cells/Stromal Cells in Treating Female Infertility: A Recent Review.

Reproductive sciences (Thousand Oaks, Calif.)·2026

Authors' Response to the Commentary on "Micronized Vaginal Progesterone Dose and Serum Progesterone Thresholds Determine Reproductive Outcomes in Frozen-Thawed Embryo Transfer With Hormone Replacement Therapy".

Reproductive medicine and biology·2026

Clinical Appraisal of "Micronized Vaginal Progesterone Dose and Serum Progesterone Thresholds Determine Reproductive Outcomes in Frozen-Thawed Embryo Transfer With Hormone Replacement Therapy".

Reproductive medicine and biology·2026

Related Experiment Videos

[Ascending urinary tract infections and vulvovesical reflux--a myth?]

Related Concept Videos

Animal pharmacokinetics of inogatran, a low-molecular-weight thrombin inhibitor with potential use as an antithrombotic drug.

In vitro effects of inogatran, a selective low molecular weight thrombin inhibitor.

Inogatran, a novel direct low molecular weight thrombin inhibitor, given with, but not after, tissue-plasminogen activator, improves thrombolysis.

Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time.

Thrombin inhibitors based on ketone derivatives of arginine and lysine.

Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.

[The Swedish Neonatal Quality Register (SNQ) - a complete register for a complex chain of events].

[Postoperative atrial fibrillation after open heart surgery].

[Interaction between psychotic patients and AI-driven chatbots].

[Superficial venous thrombosis of the lower extremities].

[Switch from STEMI to OMI].

[Maxillomandibular advancement].

Late follicular phase progesterone levels and in vitro fertilization and intracytoplasmic sperm injection outcomes.

Influencing factors of fertilization failure during in vitro fertilization.

Astaxanthin and Male Reproductive Health: Mechanisms, Experimental Evidence, and Clinical Perspectives.

Potential and Challenges of Menstrual Blood-derived Mesenchymal Stem Cells/Stromal Cells in Treating Female Infertility: A Recent Review.

Authors' Response to the Commentary on "Micronized Vaginal Progesterone Dose and Serum Progesterone Thresholds Determine Reproductive Outcomes in Frozen-Thawed Embryo Transfer With Hormone Replacement Therapy".

Clinical Appraisal of "Micronized Vaginal Progesterone Dose and Serum Progesterone Thresholds Determine Reproductive Outcomes in Frozen-Thawed Embryo Transfer With Hormone Replacement Therapy".

Related Experiment Videos

[Ascending urinary tract infections and vulvovesical reflux--a myth?]

Related Concept Videos

Related Articles